Document is current
Any future updates will be listed below
-
Authors
Miller, Matthew J. https://orcid.org/0000-0002-1301-7149
Turo, Patricia
Benjamin, Cynthia
Hoffmann, Coles
Sudore, Rebecca L.
Tang, Paul
Brodaty, Henry
Chesney, Margaret A.
Boyle, Dennis
Chao, Linda L.
Barnes, Deborah E.
-
Funding
Funding for this research was provided by:
National Institues of Health, USA (KL2TR001870, K76AG083308)
National Institutes on Aging (K24AG054415)
National Institutes on Aging (R44AG074727)
- License Information
-
More Information
Article History
Received: 26 February 2025
Accepted: 18 June 2026
First Online: 6 July 2026
Declarations
:
: All study protocols and informed consent procedures were approved by the Institutional Review Board (IRB) at the University of California, San Francisco. The study enrolled older adults with subjective cognitive decline or mild cognitive impairment; participants demonstrated understanding during screening and consent, and research staff assessed comprehension as needed to ensure informed consent. All procedures were conducted remotely, and all participants provided informed consent using IRB-approved verbal (telephone) or digital (online form with typed name and date) processes prior to participation.
: Not applicable.
: A portion of this analysis was presented at the Gerontological Society of America meeting in Tampa, FL, November 2023. Ms. Benjamin is a co-founder, share-holder, and former employee of Together Senior Health, which was acquired by Linus Health in July 2024. Ms. Turo is a former employee of Together Senior Health and Linus Health. Dr. Chesney and Dr. Barnes are co-developers of the Preventing Loss of Independence through Exercise (PLIÉ) program that serves as the foundation for Moving TogetherTM and have the potential to earn royalties. Dr. Barnes also is a co-founder, share-holder, and former Chief Science Advisor for Together Senior Health and a former consultant for Linus Health. Dr Brodaty is or has been an advisory board member or consultant to Biogen, Eisai, Eli Lilly, Medicines Australia, Roche and Skin2Neuron. He is a Medical Advisory Board member for Cranbrook Care.
